ARQT vs. QCOM
Compare and contrast key facts about Arcutis Biotherapeutics, Inc. (ARQT) and QUALCOMM Incorporated (QCOM).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ARQT or QCOM.
Correlation
The correlation between ARQT and QCOM is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ARQT vs. QCOM - Performance Comparison
Key characteristics
ARQT:
1.25
QCOM:
0.67
ARQT:
2.10
QCOM:
1.11
ARQT:
1.24
QCOM:
1.14
ARQT:
1.15
QCOM:
0.76
ARQT:
4.52
QCOM:
1.26
ARQT:
21.51%
QCOM:
19.94%
ARQT:
77.19%
QCOM:
37.70%
ARQT:
-95.02%
QCOM:
-86.75%
ARQT:
-64.58%
QCOM:
-23.01%
Fundamentals
ARQT:
$1.53B
QCOM:
$191.28B
ARQT:
-$1.67
QCOM:
$8.94
ARQT:
$125.18M
QCOM:
$29.03B
ARQT:
$112.96M
QCOM:
$16.28B
ARQT:
-$109.21M
QCOM:
$8.68B
Returns By Period
In the year-to-date period, ARQT achieves a -5.96% return, which is significantly lower than QCOM's 12.64% return.
ARQT
-5.96%
-10.40%
45.56%
117.61%
-11.99%
N/A
QCOM
12.64%
9.64%
10.16%
22.51%
16.44%
13.35%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ARQT vs. QCOM — Risk-Adjusted Performance Rank
ARQT
QCOM
ARQT vs. QCOM - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Arcutis Biotherapeutics, Inc. (ARQT) and QUALCOMM Incorporated (QCOM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ARQT vs. QCOM - Dividend Comparison
ARQT has not paid dividends to shareholders, while QCOM's dividend yield for the trailing twelve months is around 1.94%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ARQT Arcutis Biotherapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
QCOM QUALCOMM Incorporated | 1.94% | 2.18% | 2.18% | 2.67% | 1.47% | 1.69% | 2.81% | 4.27% | 3.50% | 3.17% | 3.72% | 2.17% |
Drawdowns
ARQT vs. QCOM - Drawdown Comparison
The maximum ARQT drawdown since its inception was -95.02%, which is greater than QCOM's maximum drawdown of -86.75%. Use the drawdown chart below to compare losses from any high point for ARQT and QCOM. For additional features, visit the drawdowns tool.
Volatility
ARQT vs. QCOM - Volatility Comparison
Arcutis Biotherapeutics, Inc. (ARQT) has a higher volatility of 18.93% compared to QUALCOMM Incorporated (QCOM) at 6.66%. This indicates that ARQT's price experiences larger fluctuations and is considered to be riskier than QCOM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ARQT vs. QCOM - Financials Comparison
This section allows you to compare key financial metrics between Arcutis Biotherapeutics, Inc. and QUALCOMM Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities